PT  - JOURNAL ARTICLE
AU  - Vinall, Maria
ED  - Reau, Nancy S.
ED  - Naggie, Susanna
TI  - New Treatment Paradigm for HCV and HCV/HIV Coinfection
DP  - 2015 Sep 07
TA  - MD Conference Express
PG  - 25--27
VI  - 15
IP  - 14
4099  - http://mdc.sagepub.com/content/15/14/25.short
4100  - http://mdc.sagepub.com/content/15/14/25.full
AB  - New treatment regimens utilizing combinations of protease (nonstructural protein 3-4A [NS3-4A]), nucleotide (NS5B), nonnucleoside (NS5B), and NS5A inhibitors are successfully being used to treat patients with hepatitis C virus coinfected with HIV. Sustained virologic response rates of ≥ 90% are achieved after 12 to 24 weeks in patients with and without cirrhosis who are treatment naïve and experienced. HIV is no longer a predictor of poorer response to hepatitis C virus therapy.